Featured Research

from universities, journals, and other organizations

Common protein known to cause autism now linked to specific behaviors

Date:
June 3, 2013
Source:
University of California, Los Angeles (UCLA), Health Sciences
Summary:
Researchers find abnormal brain networks in Fragile X syndrome, a genetic malady that is the most common inherited cause of autism and intellectual disability.

Fragile X syndrome (FXS) is a genetic malady that is the most common inherited cause of autism and intellectual disability. Brain scientists know the gene defect that causes FXS, and the damage it does-- misshaping the brain's synapses, the connections between neurons. But how that abnormal shaping of synapses translates to abnormal behavior is unclear.

Now researchers at UCLA believe they know. Using a mouse model of fragile X syndrome, the researchers recorded the activity of networks of neurons in a living mouse brain while the animal was both awake and asleep. They found these neuronal networks showed too much activity, firing too often and in synch, much more than a normal brain. This neuronal excitability may also be the basis for symptoms in children with FXS, which can include disrupted sleep, seizures, or learning disabilities. The findings may lead to treatments that could quiet the excessive activity and allow for more normal behavior.

The results appear in the June 2 online edition of the journal Nature Neuroscience.

According to the National Fragile X Foundation, in males, approximately 1 in 3600 to 4000 have the disorder; in females, 1 in 4000 to 6000. FXS is caused by a mutation in the gene fmr1, which encodes the fragile X mental retardation protein, FMRP. That protein is believed to be important for the formation and regulation of synapses. Mice that lack the fmr1 gene (and therefore lack the FMRP protein) show some of the same symptoms of human FXS, including seizures, impaired sleep, abnormal social relationships, and learning defects.

"We wanted to find the link between the abnormal structure of synapses in the FXS mouse, and the behavioral abnormalities at the level of brain circuits; that had not been previously established," said senior author Dr. Carlos Portera-Cailliau, an associate professor in the departments of neurology and neurobiology. "So we tested the signaling between different neurons in fragile X mice, and indeed found there was abnormally high firing of action potentials--the signals between neurons--and also abnormally high synchrony; that is, too many neurons fired together. That's a feature that is common in early brain development, but not in the adult," he said. "In essence, this points to a relative immaturity of brain circuits in FXS," added Tiago Gonηalves, a former post-doc in Portera-Cailliau's lab and first author of the study.

The researchers used two-photon calcium imaging and patch-clamp electrophysiology, two sophisticated technologies that allowed the researchers to record the signals from individual brain cells. Abnormally high firing and network synchrony, said Portera-Cailliau, is evidence of the fact that neuronal circuits are over excitable in FXS. "That likely leads to aberrant brain function or impairments in the normal computations of the brain," he said. "For example, high synchrony could lead to seizures -- more neurons firing together could cause entire portions of the brain to fire synchronously, which is the basis of seizures." And epilepsy, he notes, is seen in up to 20 percent of children with FXS.

High firing rates could also impair the ability of the brain to decode sensory stimuli, by causing an overwhelming response to even simple sensory stimuli; that could lead to autism and the withdrawal from social interactions. "Interestingly, we found that the high firing and synchrony were especially apparent at times when the animals were asleep. This is curious because a prominent symptom of FXS is disrupted sleep and frequent awakenings." And, he noted, since sleep is important for encoding memories and consolidating learning, this hyperexcitability of brain networks in FXS may interfere with the process of laying down new memories, and perhaps explain the learning disability in children with FXS.

"Because brain scientists know a lot about the factors that regulate neuronal excitability, including inhibitory neurons, they can now try to use a variety of strategies to dampen neuronal excitation. Hopefully, this may be helpful to treat symptoms of FXS," he said.

The next step, said Portera-Cailliau, is to explore whether fragile X mice indeed exhibit exaggerated responses to sensory stimuli. "Because an overwhelming reaction to a slight sound or caress, or hyperarousal to sensory stimuli, could be common to different types of autism, and not just FXS," he said. "If hyperexcitability is the brain network basis for these symptoms, then reducing neuronal excitability with certain drugs that modulate inhibition could be of therapeutic value in these devastating neurodevelopmental disorders."

Other authors on the study included Peyman Golshani of UCLA, and James A. Anstey from the Oregon Health & Science, University School of Medicine. The research was funded by grants from the National Institutes of Health (NICHD R01HD054453 and NINDS RC1NS068093), FRAXA Research Foundation and the Dana Foundation.


Story Source:

The above story is based on materials provided by University of California, Los Angeles (UCLA), Health Sciences. Note: Materials may be edited for content and length.


Journal Reference:

  1. J Tiago Gonηalves, James E Anstey, Peyman Golshani, Carlos Portera-Cailliau. Circuit level defects in the developing neocortex of Fragile X mice. Nature Neuroscience, 2013; DOI: 10.1038/nn.3415

Cite This Page:

University of California, Los Angeles (UCLA), Health Sciences. "Common protein known to cause autism now linked to specific behaviors." ScienceDaily. ScienceDaily, 3 June 2013. <www.sciencedaily.com/releases/2013/06/130603133326.htm>.
University of California, Los Angeles (UCLA), Health Sciences. (2013, June 3). Common protein known to cause autism now linked to specific behaviors. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2013/06/130603133326.htm
University of California, Los Angeles (UCLA), Health Sciences. "Common protein known to cause autism now linked to specific behaviors." ScienceDaily. www.sciencedaily.com/releases/2013/06/130603133326.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) — Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) — The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) — Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins